OMAGNA Trademark
Trademark Overview
On Thursday, January 30, 2003, a trademark application was filed for OMAGNA with the United States Patent and Trademark Office. The USPTO has given the OMAGNA trademark a serial number of 78209012. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, October 10, 2003. This trademark is owned by Agouron Pharmaceuticals, Inc.. The OMAGNA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, ophthalmological preparations, preparations for the treatment of HIV and AIDS
General Information
| Serial Number | 78209012 |
| Word Mark | OMAGNA |
| Filing Date | Thursday, January 30, 2003 |
| Status | 601 - ABANDONED - EXPRESS |
| Status Date | Friday, October 10, 2003 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 23, 2003 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, ophthalmological preparations, preparations for the treatment of HIV and AIDS |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 26, 2003 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Agouron Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | Agouron Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
Trademark Events
| Event Date | Event Description |
| Friday, October 10, 2003 | ABANDONMENT - EXPRESS MAILED |
| Friday, October 10, 2003 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Friday, September 12, 2003 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 18, 2003 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 23, 2003 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 3, 2003 | NOTICE OF PUBLICATION |
| Monday, August 18, 2003 | PAPER RECEIVED |
| Monday, July 14, 2003 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, July 11, 2003 | ASSIGNED TO EXAMINER |
